Coherus BioSciences Ownership | Who Owns Coherus BioSciences?


OverviewForecastRevenueFinancialsChartTranscripts

Coherus BioSciences Ownership Summary


Coherus BioSciences is owned by 30.75% institutional investors, 1.36% insiders, and 67.89% retail investors. Blackrock is the largest institutional shareholder, holding 10.42% of CHRS shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.96% of its assets in Coherus BioSciences shares.

CHRS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCoherus BioSciences30.75%1.36%67.89%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock11.75M10.42%$20.33M
Vanguard group11.15M9.68%$15.39M
Blackrock funding, inc. /de11.08M9.61%$15.28M
Point72 asset management5.28M4.59%$7.29M
Rubric capital management lp5.26M4.56%$7.26M
Tang capital management3.65M3.17%$5.04M
Kohlberg kravis roberts3.04M2.64%$4.15M
Geode capital management2.60M2.26%$3.59M
State street2.18M1.89%$3.00M
Cm management2.05M1.78%$2.83M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Cm management2.05M2.53%$2.83M
Tejara capital738.16K0.67%$1.02M
Tang capital management3.65M0.33%$5.04M
Stonepine capital management250.00K0.28%$345.00K
Kohlberg kravis roberts3.04M0.11%$4.15M
Rubric capital management lp5.26M0.09%$7.26M
Birchview capital, lp82.00K0.09%$113.16K
Tyche wealth partners266.77K0.08%$368.14K
Wealth group52.20K0.05%$72.00K
C worldwide group1.93M0.03%$2.66M

Top Buyers

HolderShares% AssetsChange
Point72 asset management5.28M0.02%5.28M
Tang capital management3.65M0.33%1.30M
Jacobs levy equity management1.00M0.01%1.00M
Ubs group709.00K0.00%535.83K
Blackrock11.75M0.00%521.98K

Top Sellers

HolderShares% AssetsChange
Temasek (private)---5.82M
Rubric capital management lp5.26M0.09%-5.14M
Barclays300.19K0.00%-2.17M
Bank of america corp /de/275.10K--2.15M
Goldman sachs group534.71K0.00%-1.54M

New Positions

HolderShares% AssetsChangeValue
Point72 asset management5.28M0.02%5.28M$7.29M
Norges bank491.50K0.00%491.50K$850.29K
Stonepine capital management250.00K0.28%250.00K$345.00K
Gsa capital partners llp123.02K0.01%123.02K$170.00K
Strs ohio94.60K0.00%94.60K$163.66K

Sold Out

HolderChange
Eagle bay advisors-30.00
Nelson, van denburg & campbell wealth management group-31.00
Newbridge financial services group-79.00
Rothschild investment-95.00
Harbour investments-100.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202475-42.75%35,423,873-53.96%300.69%37-35.09%18-47.06%
Sep 30, 2024131-5.07%76,943,748-5.87%661.32%57-20.83%34-2.86%
Jun 30, 2024137-4.86%81,739,8870.11%720.96%7220.00%35-35.19%
Mar 31, 2024144-11.11%81,648,5630.42%861.25%60-25.00%54-3.57%
Dec 31, 2023162-6.36%81,306,136-12.52%830.73%80-23.08%5621.74%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF3.43M2.96%-
Vanguard Total Stock Mkt Idx Inv3.43M2.96%-
iShares Russell 2000 ETF2.90M2.51%-25.14K
C WorldWide Healthcare Select 1A1.93M1.66%-
Vanguard Institutional Extnd Mkt Idx Tr1.92M1.66%-
Vanguard Strategic Equity Inv1.71M1.47%-
Vanguard Explorer Inv1.69M1.46%-
Fidelity Small Cap Index1.09M0.94%-20.34K
AlphaCentric LifeSci Healthcare I1.00M0.87%-
BlackRock Advantage Small Cap Core Instl1.00M0.86%-

Recent Insider Transactions


DateNameRoleActivityValue
Nov 22, 2023Lanfear Dennis M President & CEOSell$449.77K
Oct 15, 2021Stilwell McDavid Chief Financial OfficerSell$58.92K
Sep 28, 2021HEALY JAMES-Sell$829.81K
Sep 29, 2021HEALY JAMES-Sell$4.61M
Sep 27, 2021HEALY JAMES-Sell$1.81M

Insider Transactions Trends


DateBuySell
2025 Q1--
2024 Q4--
2024 Q3--
2024 Q2--
2024 Q1--

CHRS Ownership FAQ


Who Owns Coherus BioSciences?

Coherus BioSciences shareholders are primarily institutional investors at 30.75%, followed by 1.36% insiders and 67.89% retail investors. The average institutional ownership in Coherus BioSciences's industry, Biotech Stocks , is 68.48%, which Coherus BioSciences falls below.

Who owns the most shares of Coherus BioSciences?

Coherus BioSciences’s largest shareholders are Blackrock (11.75M shares, 10.42%), Vanguard group (11.15M shares, 9.68%), and Blackrock funding, inc. /de (11.08M shares, 9.61%). Together, they hold 29.72% of Coherus BioSciences’s total shares outstanding.

Does Blackrock own Coherus BioSciences?

Yes, BlackRock owns 10.42% of Coherus BioSciences, totaling 11.75M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 20.33M$. In the last quarter, BlackRock increased its holdings by 521.98K shares, a 4.65% change.

Who is Coherus BioSciences’s biggest shareholder by percentage of total assets invested?

Cm management is Coherus BioSciences’s biggest shareholder by percentage of total assets invested, with 2.53% of its assets in 2.05M Coherus BioSciences shares, valued at 2.83M$.

Who is the top mutual fund holder of Coherus BioSciences shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Coherus BioSciences shares, with 2.96% of its total shares outstanding invested in 3.43M Coherus BioSciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools